Mitchell S. Kapoor Analyst PerformanceAnalyst at HC WainwrightMitchell S. Kapoor is a stock analyst at HC Wainwright in the healthcare sector, covering 29 publicly traded companies. Over the past year, Mitchell S. Kapoor has issued 104 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S. Kapoor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S. Kapoor's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings104 Last 0 YearsBuy Recommendations84.62% 88 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution104RatingsDistribution of strong buy, buy, hold, and sell ratings by Mitchell S. Kapoor.RatingPercentageCount Strong Buy0.0%0 ratings Buy84.6%88 ratings Hold10.6%11 ratings Sell4.8%5 ratingsOut of 104 total stock ratings issued by Mitchell S. Kapoor at HC Wainwright, the majority (84.6%) have been Buy recommendations, followed by 10.6% Hold and 4.8% Sell.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ96.6% of companies on NASDAQ28 companiesNYSE3.4% of companies on NYSE1 companyMitchell S. Kapoor, an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare29 companies100.0%Mitchell S. Kapoor of HC Wainwright specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY28 companies96.6%PHARMACEUTICALS1 company3.4% Mitchell S. Kapoor's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIONSIonis Pharmaceuticals7/30/2026Lower Price Target$54.04$115.00Buy$0.0000.00% ROIINCYIncyte7/29/2026Boost Price Target$129.93$150.00Buy$0.0000.00% ROILEGNLegend Biotech7/28/2026Reiterated Rating$19.27$65.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/23/2026Reiterated Rating$54.01Buy$0.0000.00% ROISMMTSummit Therapeutics7/23/2026Reiterated Rating$14.74Neutral$0.0000.00% ROIINCYIncyte7/21/2026Reiterated Rating$115.65$140.00Buy$0.0000.00% ROIDMRADamora Therapeutics, Inc. Common Stock7/21/2026Reiterated Rating$32.99$45.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics7/21/2026Reiterated Rating$77.09$95.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/10/2026Lower Price Target$60.16$125.00Buy$0.0000.00% ROIMGTXMeiraGTx7/8/2026Reiterated Rating$14.66$20.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CRSPCRISPR Therapeutics7/8/2026Reiterated Rating$60.77$80.00Buy$0.0000.00% ROIINCYIncyte6/24/2026Reiterated Rating$104.40$140.00Buy$0.0000.00% ROIORKAOruka Therapeutics6/23/2026Reiterated Rating$85.38$120.00Buy$0.0000.00% ROIDMRADamora Therapeutics, Inc. Common Stock6/11/2026Initiated Coverage$20.15$45.00Buy$0.0000.00% ROILYELLyell Immunopharma6/9/2026Reiterated Rating$12.31$45.00Buy$0.0000.00% ROINGNENeurogene6/9/2026Reiterated Rating$28.60$70.00Buy$0.0000.00% ROIINCYIncyte6/9/2026Boost Price Target$103.11$140.00Buy$0.0000.00% ROILEGNLegend Biotech6/3/2026Boost Price Target$36.28$65.00Buy$0.0000.00% ROILYELLyell Immunopharma6/3/2026Reiterated Rating$14.89$45.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics6/3/2026Reiterated Rating$7.86$25.00Buy$0.0000.00% ROIEVMNEvommune5/26/2026Reiterated Rating$22.74$50.00Buy$0.0000.00% ROIKRROKorro Bio5/19/2026Lower Price Target$9.97$15.00Buy$0.0000.00% ROILEGNLegend Biotech5/18/2026Reiterated Rating$27.55$50.00Buy$0.0000.00% ROIORKAOruka Therapeutics5/18/2026Reiterated Rating$61.93$120.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/18/2026Lower Price Target$50.63$50.00Neutral$0.0000.00% ROIALMSAlumis5/15/2026Downgrade$24.63$25.00Neutral$0.0000.00% ROIKYTXKyverna Therapeutics5/15/2026Boost Price Target$10.74$25.00Buy$0.0000.00% ROITYRATyra Biosciences5/14/2026Reiterated Rating$36.18$45.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics5/14/2026Lower Price Target$19.85$35.00Buy$0.0000.00% ROINTLAIntellia Therapeutics5/13/2026Lower Price Target$13.99$25.00Buy$0.0000.00% ROIRNACCartesian Therapeutics5/12/2026Lower Price Target$8.53$25.00Buy$0.0000.00% ROICTMXCytomX Therapeutics5/11/2026Lower Price Target$3.98$11.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2026Reiterated Rating$55.46$55.00Neutral$0.0000.00% ROIINCYIncyte5/4/2026Reiterated Rating$96.91$135.00Buy$0.0000.00% ROISMMTSummit Therapeutics5/4/2026Lower Price Target$16.11$23.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics4/29/2026Boost Price Target$63.86$95.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics4/23/2026Reiterated Rating$10.23$20.00Buy$0.0000.00% ROIIPSCCentury Therapeutics4/21/2026Boost Price Target$2.34$5.00Buy$0.0000.00% ROILEGNLegend Biotech4/21/2026Reiterated Rating$25.07$50.00Buy$0.0000.00% ROISRPTSarepta Therapeutics4/16/2026Reiterated Rating$21.07Sell$0.0000.00% ROIBuy this stock today (Ad)Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.Get the name, ticker, and full Hotlist before markets openLEGNLegend Biotech4/15/2026Reiterated Rating$18.69$50.00Buy$0.0000.00% ROIINCYIncyte4/15/2026Reiterated Rating$97.69$135.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Boost Price Target$59.58$70.00Buy$0.0000.00% ROIGENBGenerate Biomedicines4/13/2026Initiated Coverage$11.41$16.00Buy$0.0000.00% ROIALMSAlumis3/30/2026Lower Price Target$24.80$25.00Buy$0.0000.00% ROIPALIPalisade Bio3/26/2026Initiated Coverage$2.00$7.00Buy$0.0000.00% ROIINCYIncyte3/25/2026Reiterated Rating$90.62$135.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics3/25/2026Boost Price Target$13.45$40.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals3/25/2026Boost Price Target$73.05$120.00Buy$0.0000.00% ROIEVMNEvommune3/18/2026Lower Price Target$24.99$50.00Buy$0.0000.00% ROICTMXCytomX Therapeutics3/16/2026Boost Price Target$7.81$17.00Buy$0.0000.00% ROIINCYIncyte3/9/2026Reiterated Rating$95.94$135.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$15.44$30.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/2/2026Reiterated Rating$16.76Sell$0.0000.00% ROICBIOCrescent Biopharma3/2/2026Lower Price Target$12.09$22.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/25/2026Lower Price Target$62.62$55.00Neutral$0.0000.00% ROISMMTSummit Therapeutics2/24/2026Lower Price Target$16.09$30.00Buy$0.0000.00% ROIINCYIncyte2/11/2026Reiterated Rating$100.05$135.00Buy$0.0000.00% ROIEVMNEvommune2/10/2026Boost Price Target$25.02$65.00Buy$0.0000.00% ROIINCYIncyte2/5/2026Initiated Coverage$102.60$135.00Buy$0.0000.00% ROISMMTSummit Therapeutics2/2/2026Reiterated Rating$14.48$40.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/27/2026Reiterated Rating$22.80Sell$0.0000.00% ROILEGNLegend Biotech1/22/2026Lower Price Target$20.76$50.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics1/15/2026Reiterated Rating$16.19$25.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/14/2026Reiterated Rating$21.46Sell$0.0000.00% ROINGNENeurogene1/13/2026Reiterated Rating$17.28$70.00Buy$0.0000.00% ROITILInstil Bio1/7/2026Reiterated Rating$7.03Neutral$0.0000.00% ROIEVMNEvommune1/6/2026Initiated Coverage$15.26$35.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical12/22/2025Boost Price Target$61.15$60.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics12/19/2025Reiterated Rating$65.11$90.00Buy$0.0000.00% ROILYELLyell Immunopharma11/24/2025Reiterated Rating$19.13$20.00Neutral$0.0000.00% ROIRNACCartesian Therapeutics11/19/2025Lower Price Target$7.62$30.00Buy$0.0000.00% ROINGNENeurogene11/13/2025Boost Price Target$31.08$70.00Buy$0.0000.00% ROIKRROKorro Bio11/13/2025Reiterated Rating$31.42Neutral$0.0000.00% ROICTMXCytomX Therapeutics11/11/2025Boost Price Target$4.19$10.00Buy$0.0000.00% ROINTLAIntellia Therapeutics11/10/2025Lower Price Target$9.52$15.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals11/10/2025Boost Price Target$73.55$110.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics10/27/2025Boost Price Target$7.44$20.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/27/2025Lower Price Target$52.67$55.00Neutral$0.0000.00% ROILXEOLexeo Therapeutics10/21/2025Lower Price Target$9.22$13.00Buy$0.0000.00% ROILEGNLegend Biotech10/17/2025Lower Price Target$32.36$60.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/15/2025Reiterated Rating$66.65$90.00Buy$0.0000.00% ROINGNENeurogene10/9/2025Reiterated Rating$28.20$45.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/8/2025Reiterated Rating$68.94$95.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/2/2025Boost Price Target$74.94$90.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics9/23/2025Reiterated Rating$62.10$80.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/23/2025Reiterated Rating$61.36$95.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics9/22/2025Boost Price Target$77.81$85.00Buy$0.0000.00% ROINTLAIntellia Therapeutics9/19/2025Boost Price Target$16.11$30.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics9/17/2025Boost Price Target$11.13$25.00Buy$0.0000.00% ROIYour $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.SMMTSummit Therapeutics9/16/2025Reiterated Rating$18.94$50.00Buy$0.0000.00% ROITILInstil Bio9/11/2025Reiterated Rating$24.16$125.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/8/2025Reiterated Rating$25.98$50.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical9/8/2025Initiated Coverage$57.77$60.00Neutral$0.0000.00% ROIEDITEditas Medicine9/5/2025Reiterated Rating$2.52$5.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/2/2025Reiterated Rating$23.70$50.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/2/2025Boost Price Target$42.63$95.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics8/29/2025Boost Price Target$3.70$10.00Buy$0.0000.00% ROICBIOCrescent Biopharma8/27/2025Reiterated Rating$14.47$25.00Buy$0.0000.00% ROITILInstil Bio8/27/2025Reiterated Rating$28.41$125.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/25/2025Reiterated Rating$20.22Sell$0.0000.00% ROIIONSIonis Pharmaceuticals8/22/2025Boost Price Target$43.24$70.00Buy$0.0000.00% ROITYRATyra Biosciences8/22/2025Reiterated Rating$11.70$30.00Buy$0.0000.00% ROIEDITEditas Medicine8/15/2025Boost Price Target$2.96$5.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupThe Goldman Sachs GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
